|
US2978453A
(en)
|
1956-12-12 |
1961-04-04 |
Aerojet General Co |
3, 3, 5, 5-tetranitropiperidine
|
|
JPS4830376B1
(enExample)
|
1970-12-29 |
1973-09-19 |
|
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
JPS5511509A
(en)
|
1978-07-07 |
1980-01-26 |
Toomasu Gorudon Robaato |
Cancer therapy
|
|
US4935450A
(en)
|
1982-09-17 |
1990-06-19 |
Therapeutical Systems Corporation |
Cancer therapy system for effecting oncolysis of malignant neoplasms
|
|
GB8504253D0
(en)
|
1985-02-19 |
1985-03-20 |
Ici Plc |
Electrostatic spraying apparatus
|
|
US4584130A
(en)
|
1985-03-29 |
1986-04-22 |
University Of Maryland |
Intramolecularly cross-linked hemoglobin and method of preparation
|
|
GB8728418D0
(en)
|
1987-12-04 |
1988-01-13 |
Jenkins T C |
Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
|
|
DE3815221C2
(de)
|
1988-05-04 |
1995-06-29 |
Gradinger F Hermes Pharma |
Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
|
|
US5693794A
(en)
|
1988-09-30 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Navy |
Caged polynitramine compound
|
|
JP2659614B2
(ja)
|
1990-11-13 |
1997-09-30 |
株式会社日立製作所 |
表示制御装置
|
|
TW198712B
(enExample)
|
1991-04-17 |
1993-01-21 |
Hoffmann La Roche |
|
|
US5698155A
(en)
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
|
DE69226197T2
(de)
|
1991-11-08 |
1999-02-11 |
Somatogen, Inc., Boulder |
Hämoglobine als arzneimittelabgabesystem
|
|
DE4226974C2
(de)
|
1992-08-14 |
1994-08-11 |
Fresenius Ag |
Verfahren und Vorrichtung zur kontinuierlichen Aufbereitung einer Zellsuspension
|
|
US5336784A
(en)
|
1993-06-07 |
1994-08-09 |
The Regents Of The University Of California |
Synthesis of 1,3,3-trinitroazetidine
|
|
PT1051972E
(pt)
|
1994-05-27 |
2007-12-07 |
Strakan Internat Ltd Uma Socie |
Composição dadora de óxido nítrico para tratamento de distúrbios anais
|
|
JP4155594B2
(ja)
|
1994-12-22 |
2008-09-24 |
アストラゼネカ・アクチエボラーグ |
エアゾール製剤
|
|
EP0814860B1
(en)
|
1995-03-14 |
1999-11-03 |
Siemens Aktiengesellschaft |
Ultrasonic atomizer device with removable precision dosating unit
|
|
DK0814861T3
(da)
|
1995-03-14 |
2002-10-07 |
Siemens Ag |
Udskiftelig præcisionsdoseringsenhed til ultralydforstøveranordning
|
|
WO1996036602A1
(en)
|
1995-05-15 |
1996-11-21 |
The United States Of America |
Adnaz, compositions and processes
|
|
US5580988A
(en)
|
1995-05-15 |
1996-12-03 |
The United States Of America As Represented By The Secretary Of The Army |
Substituted azetidines and processes of using them
|
|
US5898038A
(en)
|
1996-03-19 |
1999-04-27 |
Board Of Regents, The University Of Texas System |
Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
|
|
AU738341B2
(en)
|
1996-10-11 |
2001-09-13 |
Abbott Gmbh & Co. Kg |
Asparate ester inhibitors of interleukin-1beta converting enzyme
|
|
IL128589A0
(en)
|
1996-10-15 |
2000-01-31 |
Eastman Chem Co |
Explosive formulations
|
|
US5945446A
(en)
|
1997-02-10 |
1999-08-31 |
Laubc Biochemicals, Corporation |
Process for preparing synthetic soil-extract materials and medicaments based thereon
|
|
HUP9701554D0
(en)
|
1997-09-18 |
1997-11-28 |
Human Oltoanyagtermeloe Gyogys |
Pharmaceutical composition containing plazma proteins
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
GB9720797D0
(en)
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
|
NZ504021A
(en)
|
1997-10-17 |
2003-04-29 |
Systemic Pulmonary Delivery Lt |
Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
|
|
US6056966A
(en)
|
1998-05-18 |
2000-05-02 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for treating impotence
|
|
CA2337690C
(en)
|
1998-07-27 |
2013-10-01 |
Texas Pharmaceuticals, Inc. |
Chemically induced intracellular hyperthermia
|
|
US6448253B1
(en)
|
1998-09-16 |
2002-09-10 |
King Pharmaceuticals Research And Development, Inc. |
Adenosine A3 receptor modulators
|
|
US6391911B1
(en)
|
1999-02-26 |
2002-05-21 |
Robert E. Bases |
Coadministration of lucanthone and radiation for treatment of cancer
|
|
US20020077276A1
(en)
|
1999-04-27 |
2002-06-20 |
Fredeking Terry M. |
Compositions and methods for treating hemorrhagic virus infections and other disorders
|
|
US6245799B1
(en)
|
1999-11-08 |
2001-06-12 |
American Home Products Corp |
[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
|
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
|
CZ20023213A3
(cs)
|
2000-04-10 |
2003-12-17 |
Pfizer Products Inc. |
Benzoamidové piperidinové sloučeniny a příbuzné sloučeniny
|
|
US6861530B2
(en)
|
2000-07-07 |
2005-03-01 |
Kyowa Hakko Kogyo Co., Ltd. |
Piperidine derivatives
|
|
RU2188026C1
(ru)
|
2001-01-12 |
2002-08-27 |
Ростовский научно-исследовательский онкологический институт |
Способ лечения рака почки
|
|
DE10111049A1
(de)
|
2001-03-06 |
2002-09-12 |
Beiersdorf Ag |
Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
|
|
US20050070872A1
(en)
|
2001-12-28 |
2005-03-31 |
Kenichi Sato |
Blood bag system and method of inactivating pathogenic microorganisms
|
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
|
WO2004004648A2
(en)
|
2002-07-03 |
2004-01-15 |
Nitromed, Inc. |
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
WO2004032864A2
(en)
|
2002-10-07 |
2004-04-22 |
Radiorx, Inc. |
X-nitro compounds, pharmaceutical compositions thereof and uses therof
|
|
US6870061B2
(en)
|
2003-01-10 |
2005-03-22 |
Alliant Techsystems Inc. |
Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
|
|
WO2004098538A2
(en)
|
2003-03-13 |
2004-11-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds, compositions and methods of use
|
|
ES2358801T3
(es)
|
2003-06-25 |
2011-05-13 |
Je Il Pharmaceutical Co., Ltd. |
Derivados tricíclicos o sales farmacéuticamente aceptables de los mismos, sus preparaciones y composiciones farmacéuticas que los contienen.
|
|
US20040265238A1
(en)
|
2003-06-27 |
2004-12-30 |
Imtiaz Chaudry |
Inhalable formulations for treating pulmonary hypertension and methods of using same
|
|
AU2004255268B2
(en)
|
2003-07-09 |
2010-04-01 |
Loma Linda University |
Use of nitrite salts for the treatment of cardiovascular conditions
|
|
GB0326047D0
(en)
|
2003-11-07 |
2003-12-10 |
Univ Sheffield |
Substance
|
|
RU2265440C2
(ru)
|
2004-01-13 |
2005-12-10 |
Ростовский научно-исследовательский онкологический институт МЗ РФ |
Способ предоперационного лечения рака молочной железы
|
|
CA2579096C
(en)
|
2004-09-08 |
2012-11-13 |
Chelsea Therapeutics, Inc. |
Quinazoline derivatives as metabolically inert antifolate compounds
|
|
AU2006228957A1
(en)
|
2005-04-01 |
2006-10-05 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
US8367734B1
(en)
|
2005-08-11 |
2013-02-05 |
Amphastar Pharmaceuticals Inc. |
Stable epinephrine suspension formulation with high inhalation delivery efficiency
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
KR20080054417A
(ko)
|
2005-09-27 |
2008-06-17 |
노파르티스 아게 |
카르복시아민 화합물 및 ｈｄａｃ 의존성 질환의 치료에있어서의 그의 용도
|
|
FR2891843A1
(fr)
|
2005-10-06 |
2007-04-13 |
Erytech Pharma Soc Par Actions |
Erythrocytes contenant du 5-fluorouracile
|
|
CN200946766Y
(zh)
|
2006-06-09 |
2007-09-12 |
刘余厚 |
一种套管式紫外灯
|
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
US8122281B2
(en)
|
2007-04-13 |
2012-02-21 |
International Business Machines Corporation |
System and method for dependent failure-aware allocation of distributed data-processing systems
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
MX2010011165A
(es)
|
2008-04-10 |
2011-02-22 |
Abraxis Bioscience Llc |
Composiciones de derivados de taxano hidrofobos y sus usos.
|
|
EP2128133A1
(en)
|
2008-05-26 |
2009-12-02 |
Lek Pharmaceuticals D.D. |
Ezetimibe process and composition
|
|
BRPI1006722A2
(pt)
|
2009-04-09 |
2017-10-10 |
Entegrion Inc |
"método de preparação de hemoderivados desidratado, hemoderivados desidratados, bandagem ou auxílio cirúrgico, método para a preparação de plaquetas sanguíneas fixas desidratadas, plaquetas sanguíneas fixas desidratadas, método para o tratamento de um paciente que sofre de um distúrbio sanguíneo e plaquetas de sangue fixas secas por atomização tendo geometria com cavidades esféricas"
|
|
BRPI1014160A2
(pt)
|
2009-04-10 |
2015-08-25 |
Abraxis Bioscience Llc |
Formulações de nanopartículas e aplicações das mesmas
|
|
CN101708337B
(zh)
|
2009-08-18 |
2011-08-10 |
上海交通大学医学院附属新华医院 |
一种包载奥沙利铂的人血白蛋白纳米粒的制备方法
|
|
RU2411953C1
(ru)
|
2009-09-02 |
2011-02-20 |
Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт" Федерального агентства по высокотехнологичной мед. помощи |
Способ лечения рака молочной железы
|
|
US8471041B2
(en)
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
|
US20120149678A1
(en)
*
|
2010-12-09 |
2012-06-14 |
Oronsky Bryan T |
Organonitro Compounds for Use in Treating Non-Hodgkin's Lymphoma and Leukemia, and Methods Relating Thereto
|
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
|
EP2763667B1
(en)
|
2011-10-07 |
2022-10-26 |
EpicentRx, Inc. |
Organonitro thioether compounds and medical uses thereof
|
|
US20140308260A1
(en)
*
|
2011-10-07 |
2014-10-16 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
US8530461B2
(en)
|
2011-12-29 |
2013-09-10 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives
|
|
EP2687225A1
(en)
|
2012-07-19 |
2014-01-22 |
Alfact Innovation |
HIP/PAP protein and derivatives thereof for use in treating cancer
|
|
WO2014039960A1
(en)
|
2012-09-10 |
2014-03-13 |
Celgene Corporation |
Methods for the treatment of locally advanced breast cancer
|
|
CA2917403C
(en)
|
2013-08-27 |
2018-05-29 |
Halliburton Energy Services, Inc. |
Energetic cocrystals for treatment of a subterranean formation
|
|
US20140220163A1
(en)
|
2014-02-04 |
2014-08-07 |
Hamzeh Soleimani Babadi |
Powder mixture composition of natural materials for controlling deficiencies in polypeptide alpha and beta hemoglobin chains
|
|
FR3017299B1
(fr)
|
2014-02-12 |
2018-05-18 |
Erytech Pharma |
Composition pharmaceutique comprenant des erythrocytes encapsulant une enzyme a plp et son cofacteur
|
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
|
EA201891606A1
(ru)
|
2016-01-11 |
2019-02-28 |
Эписентарикс, Инк. |
Композиции и способы для внутривенного введения 2-бром-1-(3,3-динитроазетидин-1-ил)этанона
|
|
JP7332469B2
(ja)
|
2016-10-14 |
2023-08-23 |
エピセントアールエックス，インコーポレイテッド |
スルホキシアルキル有機窒素および関連のある化合物ならびに医学における使用のための医薬組成物
|
|
WO2019010447A1
(en)
|
2017-07-07 |
2019-01-10 |
Epicentrx, Inc. |
COMPOSITIONS FOR PARENTERAL ADMINISTRATION OF THERAPEUTIC AGENTS
|
|
WO2019164593A2
(en)
|
2018-01-08 |
2019-08-29 |
Epicentrx, Inc. |
Methods and compositions utilizing rrx-001 combination therapy for radioprotection
|
|
US20200345689A1
(en)
|
2018-01-08 |
2020-11-05 |
Epicentrx, Inc. |
METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION
|
|
EP3801678A4
(en)
|
2018-06-11 |
2022-04-06 |
EpicentRx, Inc. |
MEDICATION INFUSION DEVICES, SYSTEMS AND METHODS
|
|
CN115243741A
(zh)
|
2019-12-11 |
2022-10-25 |
埃皮辛特瑞柯斯公司 |
药物输注装置、系统和方法
|
|
CN116348123A
(zh)
|
2020-09-29 |
2023-06-27 |
浩峰生物科技股份有限公司 |
樟芝酸h及其衍生物用于治疗中枢神经系统疾病的用途
|
|
CN114621125B
(zh)
|
2020-12-14 |
2024-07-09 |
中国科学技术大学 |
Nlrp3炎症小体抑制剂及其应用
|
|
CA3221351A1
(en)
|
2021-06-09 |
2022-12-15 |
Bryan T. Oronsky |
Crystalline abdnaz compositions and methods of making and using the same
|